DVA Update: Data and Best Practices 2 Years After Promising Results

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Amgen; Boehringer Ingelheim; Bard Medical; Cook Medical; Inari Medical</li><li>Equity/Stock(s)/Options - FastWave Medical</li></ul>